Bioinformatics Analysis of Pancreas Cancer Genome in High-Throughput Genomic Technologies

Molecular Diagnostics and Treatment of Pancreatic Cancer

Volumn , Issue , 2014, Pages 93-131

  Santa Pau, Enrique Carrillo de ^a   Real, Francisco X ^a   Valencia, Alfonso ^a  

^a Centro Nacional de Investigations Oncológicas   (Spain)

Author keywords

Bioinformatics; Cancer; Genomics; Microarrays; Next generation sequencing; Pancreas

Indexed keywords

EID: 84903249849     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-408103-1.00005-4     Document Type: Chapter

References (98)

1. International Human Genome Sequencing Consortium Finishing the euchromatic sequence of the human genome. Nature 2004, 431:931-945.
2. Stratton M.R., Campbell P.J., Futreal P.A. The cancer genome. Nature 2009, 458(7239):719-724.
3. Nik-Zainal S., Alexandrov L.B., Wedge D.C., Van Loo P., Greenman C.D., Raine K., et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012, 149(5):979-993.
4. Nik-Zainal S., Van Loo P., Wedge D.C., Alexandrov L.B., Greenman C.D., Lau K.W., et al. The life history of 21 breast cancers. Cell 2012, 149(5):994-1007.
5. Biankin A.V., Waddell N., Kassahn K.S., Gingras M.C., Muthuswamy L.B., Johns A.L., et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012, 491(7424):399-405.
6. Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002, 32(Suppl.):496-501.
7. Welsh J.B., Sapinoso L.M., Su A.I., Kern S.G., Wang-Rodriguez J., Moskaluk C.A., et al. Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res 2001, 61:5974-5978.
8. Yu Z., Ford B.N., Glickman B.W. Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays. Environ Mol Mutagen 2000, 36:201-205.
9. Jiang L., Schlesinger F., Davis C.A., Zhang Y., Li R., Salit M., et al. Synthetic spike-in standards for RNA-seq experiments. Genome Res 2011, 21:1543-1551.
10. Smyth G.K. Limma: linear models for microarray data. Bioinformatics and computational biology solutions using R and bioconductor 2005, 397-420. Springer, New York. R. Gentleman, V. Carey, S. Dudoit, R. Irizarry, W. Huber (Eds.).
11. Carro A., Rico D., Rueda O.M., Díaz-Uriarte R., Pisano D.G. waviCGH: a web application for the analysis and visualization of genomic copy number alterations. Nucleic Acids Res 2010, 38:W182-W187.
12. Crnogorac-Jurcevic T., Missiaglia E., Blaveri E., Gangeswaran R., Jones M., Terris B., et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S100 genes is highly prevalent. J Pathol 2003, 201(1):63-74.
13. Iacobuzio-Donahue C.A., Maitra A., Olsen M., Lowe A.W., van Heek N.T., Rosty C., et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays. Am J Pathol 2003, 162(4):1151-1162.
14. Logsdon C.D., Simeone D.M., Binkley C., Arumugam T., Greenson J.K., Giordano T.J., et al. Molecular profiling of pancreatic adenocarcinoma and chronic pancreatitis identifies multiple genes differentially regulated in pancreatic cancer. Cancer Res 2003, 63(10):2649-2657.
15. Friess H., Ding J., Kleeff J., Fenkell L., Rosinski J.A., Guweidhi A., et al. Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 2003, 60(6):1180-1199.
16. Grützmann R., Boriss H., Ammerpohl O., Lüttges J., Kalthoff H., Schackert H.K., et al. Meta-analysis of microarray data on pancreatic cancer defines a set of commonly dysregulated genes. Oncogene 2005, 24(32):5079-5088.
17. Badea L., Herlea V., Dima S.O., Dumitrascu T., Popescu I. Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 2008, 55(88):2016-2027.
18. Collisson E.A., Sadanandam A., Olson P., Gibb W.J., Truitt M., Gu S., et al. Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy. Nat Med 2011, 17(4):500-503.
19. Donahue T.R., Tran L.M., Hill R., Li Y., Kovochich A., Calvopina J.H., et al. Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res 2012, 18(5):1352-1363.
20. López-Casas P.P., López-Fernández L.A. Gene-expression profiling in pancreatic cancer. Expert Rev Mol Diagn 2010, 10(5):591-601.
21. Gadaleta E., Cutts R.J., Kelly G.P., Crnogorac-Jurcevic T., Kocher H.M., Lemoine N.R., et al. A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws. Nucleic Acids Res 2011, 39(18):7900-7907.
22. Dorrell C., Schug J., Lin C.F., Canaday P.S., Fox A.J., Smirnova O., et al. Transcriptomes of the major human pancreatic cell types. Diabetologia 2011, 54(11):2832-2844.
23. Petersen G.M., Amundadottir L., Fuchs C.S., Kraft P., Stolzenberg-Solomon R.Z., Jacobs K.B., et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010, 42(3):224-228.
24. Holmstrom S.R., Deering T., Swift G.H., Poelwijk F.J., Mangelsdorf D.J., Kliewer S.A., et al. LRH-1 and PTF1-L coregulate an exocrine pancreas-specific transcriptional network for digestive function. Genes Dev 2011, 25(16):1674-1679.
25. Tzatsos A., Paskaleva P., Ferrari F., Deshpande V., Stoykova S., Contino G., et al. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs. J Clin Invest 2013, 123(2):727-739.
26. Ho J.W., Bishop E., Karchenko P.V., Nègre N., White K.P., Park P.J. ChIP-chip versus ChIP-seq: lessons for experimental design and data analysis. BMC Genomics 2011, 2:134.
27. Landt S.G., Marinov G.K., Kundaje A., Kheradpour P., Pauli F., Batzoglou S., et al. ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia. Genome Res 2012, 22(9):1813-1831.
28. http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc.
29. Hummel M., Bonnin S., Lowy E., Roma G. TEQC: an R package for quality control in target capture experiments. Bioinformatics 2011, 27(9):1316-1317.
30. Flicek P., Ahmed I., Amode M.R., Barrell D., Beal K., Brent S., et al. Ensembl 2013. Nucleic Acids Res 2013, 41(Database issue):D48-D55.
31. Meyer L.R., Zweig A.S., Hinrichs A.,S., Karolchik D., Kuhn R.M., Wong M., et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic Acids Res 2012, 41(D1):D64-D69.
32. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., et al. The human genome browser at UCSC. Genome Res 2002, 12(6):996-1006.
33. Li H., Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009, 25:1754-1760.
34. Langmead B., Trapnell C., Pop M., Salzberg S.L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol 2009, 10(3):R25.
35. Homer N., Merriman B., Nelson S.F. BFAST: an alignment tool for large scale genome resequencing. PLoS One 2009, 4(11):e7767.
36. Wilbanks E.G., Facciotti M.T. Evaluation of algorithm performance in ChIP-seq peak detection. PLoS One 2010, 5(7):e11471.
37. Kidder B.L., Hu G., Zhao K. ChIP-Seq: technical considerations for obtaining high-quality data. Nat Immunol 2011, 12:918-922.
38. Vega V.B., Cheung E., Palanisamy N., Sung W.K. Inherent signals in sequencing-based Chromatin-ImmunoPrecipitation control libraries. PLoS One 2009, 4(4):e5241.
39. Teytelman L., Ozaydin B., Zill O., Lefrançois P., Snyder M., Rine J., et al. Impact of chromatin structures on DNA processing for genomic analyses. PLoS One 2009, 4(8):e6700.
40. Laajala T.D., Raghav S., Tuomela S., Lahesmaa R., Aittokallio T., Elo L.L. A practical comparison of methods for detecting transcription factor binding sites in ChIP-seq experiments. BMC Genomics 2009, 10:618.
41. Micsinai M., Parisi F., Strino F., Asp P., Dynlacht B.D., Kluger Y. Picking ChIP-seq peak detectors for analyzing chromatin modification experiments. Nucleic Acids Res 2012, 40(9):e70.
42. Matys V., Kel-Margoulis O.V., Fricke E., Liebich I., Land S., Barre-Dirrie A., et al. TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes. Nucleic Acids Res 2006, 34:D108-D110.
43. Bryne J.C., Valen E., Tang M.H., Marstrand T., Winther O., da Piedade I., et al. JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update. Nucleic Acids Res 2008, 36:D102-D106.
44. Bailey T.L., Bodén M., Buske F.A., Frith M., Grant C.E., Clementi L., et al. MEME SUITE: tools for motif discovery and searching. Nucleic Acids Res 2009, 37:W202-W208.
45. Salmon-Divon M., Dvinge H., Tammoja K., Bertone P. PeakAnalyzer: genome-wide annotation of chromatin binding and modification loci. BMC Bioinformatics 2010, 11:415.
46. Zhu L.J., Gazin C., Lawson N.D., Pagès H., Lin S.M., Lapointe D.S., et al. ChIPpeakAnno: a Bioconductor package to annotate ChIP-seq and ChIP-chip data. BMC Bioinformatics 2010, 11:237.
47. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
48. Liberzon A., Subramanian A., Pinchback R., Thorvaldsdóttir H., Tamayo P., Mesirov J.P. Molecular signatures database (MSigDB) 3.0. Bioinformatics 2011, 27(12):1739-1740.
49. Hebenstreit D., Gu M., Haider S., Turner D.J., Liò P., Teichmann S.A. EpiChIP: gene-by-gene quantification of epigenetic modification levels. Nucleic Acids Res 2011, 39(5):e27.
50. Ye T., Krebs A.R., Choukrallah M.A., Keime C., Plewniak F., Davidson I., et al. seqMINER: an integrated ChIP-seq data interpretation platform. Nucleic Acids Res 2011, 39(6):e35.
51. Crawford G.E., Holt I.E., Whittle J., Webb B.D., Tai D., Davis S., et al. Genome-wide mapping of DNase hypersensitive sites using massively parallel signature sequencing (MPSS). Genome Res 2006, 16(1):123-131.
52. Giresi P.G., Kim J., Mc Daniell R.M., Iyer V.R., Lieb J.D. FAIRE (Formaldehyde-Assisted Isolation of Regulatory Elements) isolates active regulatory elements from human chromatin. Genome Res 2007, 17(6):877-885.
53. Boyle A.P., Guinney J., Crawford G.E., Furey T.S. F-Seq: a feature density estimator for high-throughput sequence tags. Bioinformatics 2008, 24(21):2537-2538.
54. Cui K., Zhao K. Genome-wide approaches to determining nucleosome occupancy in metazoans using MNase-Seq. Methods Mol Biol 2012, 833:413-419.
55. Ernst J., Kellis M. ChromHMM: automating chromatin-state discovery and characterization. Nat Methods 2012, 9(3):215-216.
56. Hoffman M.M., Buske O.J., Wang J., Weng Z., Bilmes J.A., Noble W.S. Unsupervised pattern discovery in human chromatin structure through genomic segmentation. Nat Methods 2012, 9(5):473-476.
57. Nookaew I., Papini M., Pornputtpong N., Scalcinati G., Fagerberg L., Uhlén M., et al. A comprehensive comparison of RNA-Seq-based transcriptome analysis from reads to differential gene expression and cross-comparison with microarrays: a case study in Saccharomyces cerevisiae. Nucleic Acids Res 2012, 40:10084-10097.
58. Marioni J.C., Mason C.E., Mane S.M., Stephens M., Gilad Y. RNA-seq: an assessment of technical reproducibility and comparison with gene expression arrays. Genome Res 2008, 18:1509-1517.
59. Mortazavi A., Williams B.A., Mc Cue K., Schaeffer L., Wold B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 2008, 5:621-628.
60. Oshlack A., Wakefield M.J. Transcript length bias in RNA-seq data confounds systems biology. Biol Direct 2009, 4:14.
61. Bullard J.H., Purdom E.A., Hansen K.D., Durinck S., Dudoit S. Statistical inference in mRNA-seq: exploratory data analysis and differential expression. UC Berkeley Division of Biostatistics Working Paper Series 2009, 247.
62. http://encodeproject.org/ENCODE/protocols/dataStandards/RNA_standards_v1_2011_May.pdf.
63. Toung J.M., Morley M., Li M., Cheung V.G. RNA-sequence analysis of human B-cells. Genome Res 2011, 21(6):991-998.
64. Trapnell C., Pachter L., Salzberg S.L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 2009, 25(9):1105-1111.
65. Zerbino D.R., Birney E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 2008, 18(5):821-829.
66. Kvam V.M., Liu P., Si Y. A comparison of statistical methods for detecting differentially expressed genes from RNA-seq data. Am J Bot 2012, 99(2):248-256.
67. Robles J.A., Qureshi S.E., Stephen S.J., Wilson S.R., Burden C.J., Taylor J.M. Efficient experimental design and analysis strategies for the detection of differential expression using RNA-sequencing. BMC Genomics 2012, 13:484.
68. Nookaew I., Papini M., Pornputtpong N., Scalcinati G., Fagerberg L., Uhlén M., et al. A comprehensive comparison of RNA-Seq-based transcriptome analysis from reads to differential gene expression and cross-comparison with microarrays: a case study in Saccharomyces cerevisiae. Nucleic Acids Res 2012, 14:91.
69. Pastrello C., Otasek D., Fortney K., Agapito G., Cannataro M., Shirdel E., et al. Visual data mining of biological networks: one size does not fit all. PLoS Comput Biol 2013, 9(1):e1002833.
70. Szklarczyk D., Franceschini A., Kuhn M., Simonovic M., Roth A., Minguez P., et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011, 39:D561-D568.
71. Ku G.M., Kim H., Vaughn I.W., Hangauer M.J., Myung Oh C., German M.S., et al. Research resource: RNA-Seq reveals unique features of the pancreatic β-cell transcriptome. Mol Endocrinol 2012, 26(10):1783-1792.
72. Eizirik D.L., Sammeth M., Bouckenooghe T., Bottu G., Sisino G., Igoillo-Esteve M., et al. The human pancreatic islet transcriptome: expression of candidate genes for type 1 diabetes and the impact of pro-inflammatory cytokines. PLoS Genet 2012, 8(3):e1002552.
73. Bramswig N.C., Everett L.J., Schug J., Dorrell C., Liu C., Luo Y., et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming. J Clin Invest 2013, 123(3):1275-1284.
74. Morán I., Akerman I., van de Bunt M., Xie R., Benazra M., Nammo T., et al. Human β cell transcriptome analysis uncovers lncRNAs that are tissue-specific, dynamically regulated, and abnormally expressed in type 2 diabetes. Cell Metab 2012, 16(4):435-448.
75. Rodríguez-Seguel E., Mah N., Naumann H., Pongrac I.M., Cerdá-Esteban N., Fontaine J.F., et al. Mutually exclusive signaling signatures define the hepatic and pancreatic progenitor cell lineage divergence. Genes Dev 2013, 27(17):1932-1946.
76. Yu M., Ting D.T., Stott S.L., Wittner B.S., Ozsolak F., Paul S., et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 2012, 487(7408):510-513.
77. Rubio-Camarillo M., Gómez-López G., Fernández J.M., Valencia A., Pisano D.G. RUbioSeq: a suite of parallelized pipelines to automate exome variation and bisulfite-seq analyses. Bioinformatics 2013, 29(13):1687-1689.
78. Thorvaldsdóttir H., Robinson J.T., Mesirov J.P. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013, 14(2):178-192.
79. Kumar P., Henikoff S., Ng P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009, 4(7):1073-1081.
80. Adzhubei I.A., Schmidt S., Peshkin L., Ramensky V.E., Gerasimova A., Bork P., et al. A method and server for predicting damaging missense mutations. Nat Methods 2010, 7(4):248-249.
81. Mc Laren W., Pritchard B., Rios D., Chen Y., Flicek P., Cunningham F. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. BMC Bioinformatics 2010, 26(16):2069-2070.
82. Gonzalez-Perez A., Lopez-Bigas N. Functional impact bias reveals cancer drivers. Nucleic Acids Res 2012, 40(21):e169.
83. Lawrence M.S., Stojanov P., Polak P., Kryukov G.V., Cibulskis K., Sivachenko A., et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013 Jul 11, 499(7457):214-248.
84. Punta M., Coggill P.C., Eberhardt R.Y., Mistry J., Tate J., Boursnell C., et al. The Pfam protein families database. Nucleic Acids Res 2012, 40:D290-D301.
85. Vazquez M., de la Torre V., Valencia A. Cancer genome analysis. PLoS Comput Biol 2012, 8(12):e1002824.
86. Stephens P.J., Greenman C.D., Fu B., Yang F., Bignell G.R., Mudie L.J., et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011, 144(1):27-40.
87. Villarroel M.C., Rajeshkumar N.V., Garrido-Laguna I., De Jesus-Acosta A., Jones S., Maitra A., et al. Personalizing cancer treatment in the age of global genomic analyses: PALB2 gene mutations and the response to DNA damaging agents in pancreatic cancer. Mol Cancer Ther 2011, 10(1):3-8.
88. Jones S., Zhang X., Parsons D.W., Lin J.C., Leary R.J., Angenendt P., et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008, 321(5897):1801-1806.
89. Jones S., Hruban R.H., Kamiyama M., Borges M., Zhang X., Parsons D.W., et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009, 324(5924):217.
90. Roberts N.J., Jiao Y., Yu J., Kopelovich L., Petersen G.M., Bondy M.L., et al. ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2012, 2(1):41-46.
91. Wu J., Jiao Y., Dal Molin M., Maitra A., de Wilde R.F., Wood L.D., et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci USA 2011, 108(52):21188-21193.
92. Furukawa T., Kuboki Y., Tanji E., Yoshida S., Hatori T., Yamamoto M., et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011, 1:161.
93. Yachida S., Jones S., Bozic I., Antal T., Leary R., Fu B., et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 2010, 467(7319):1114-1117.
94. Campbell P.J., Yachida S., Mudie L.J., Stephens P.J., Pleasance E.D., Stebbings L.A., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467(7319):1109-1113.
95. Haeno H., Gonen M., Davis M.B., Herman J.M., Iacobuzio-Donahue C.A., Michor F. Computational modeling of pancreatic cancer reveals kinetics of metastasis suggesting optimum treatment strategies. Cell 2012, 148(1-2):362-375.
96. Kalyana-Sundaram S., Kumar-Sinha C., Shankar S., Robinson D.R., Wu Y.M., Cao X., et al. Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 2012, 149(7):1622-1634.
97. GTEx Consortium The Genotype-Tissue Expression (GTEx) project. Nat Genet 2013, 45(6):580-585.
98. Meredith D.M., Borromeo M.D., Deering T.G., Casey B.H., Savage T.K., Mayer P.R., et al. Program specificity for Ptf1a in pancreas versus neural tube development correlates with distinct collaborating cofactors and chromatin accessibility. Mol Cell Biol 2013, 33(16):3166-3179.